Go Pro

Kewaunee Scientific (KEQU) Competitors

Kewaunee Scientific logo
$34.16 +0.25 (+0.74%)
Closing price 04:00 PM Eastern
Extended Trading
$34.40 +0.25 (+0.72%)
As of 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KEQU vs. OBIO, SI, OFIX, RCEL, and MOBI

Should you buy Kewaunee Scientific stock or one of its competitors? Kewaunee Scientific's main competitors and comparable companies include Orchestra BioMed (OBIO), Shoulder Innovations (SI), Orthofix Medical (OFIX), Avita Medical (RCEL), and Mobia Medical (MOBI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kewaunee Scientific compare to Orchestra BioMed?

Orchestra BioMed (NASDAQ:OBIO) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Kewaunee Scientific has higher revenue and earnings than Orchestra BioMed. Orchestra BioMed is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orchestra BioMed$33.48M10.65-$52.70M-$0.85N/A
Kewaunee Scientific$282M0.35$9.62M$2.7612.49

Orchestra BioMed has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

53.2% of Orchestra BioMed shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 7.5% of Orchestra BioMed shares are held by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Orchestra BioMed and Orchestra BioMed both had 1 articles in the media. Orchestra BioMed's average media sentiment score of 0.00 equaled Kewaunee Scientific'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orchestra BioMed
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kewaunee Scientific has a net margin of 2.97% compared to Orchestra BioMed's net margin of -184.60%. Kewaunee Scientific's return on equity of 11.61% beat Orchestra BioMed's return on equity.

Company Net Margins Return on Equity Return on Assets
Orchestra BioMed-184.60% -149.61% -54.15%
Kewaunee Scientific 2.97%11.61%4.82%

Orchestra BioMed presently has a consensus price target of $13.17, suggesting a potential upside of 121.85%. Given Orchestra BioMed's stronger consensus rating and higher possible upside, equities research analysts plainly believe Orchestra BioMed is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orchestra BioMed
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Kewaunee Scientific beats Orchestra BioMed on 9 of the 14 factors compared between the two stocks.

How does Kewaunee Scientific compare to Shoulder Innovations?

Kewaunee Scientific (NASDAQ:KEQU) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Kewaunee Scientific has a net margin of 2.97% compared to Shoulder Innovations' net margin of -58.33%. Kewaunee Scientific's return on equity of 11.61% beat Shoulder Innovations' return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific2.97% 11.61% 4.82%
Shoulder Innovations -58.33%-23.61%-19.53%

Kewaunee Scientific has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.57, meaning that its share price is 257% less volatile than the broader market.

32.7% of Kewaunee Scientific shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Shoulder Innovations had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Shoulder Innovations and 1 mentions for Kewaunee Scientific. Shoulder Innovations' average media sentiment score of 0.67 beat Kewaunee Scientific's score of 0.00 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Shoulder Innovations
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kewaunee Scientific has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.35$9.62M$2.7612.49
Shoulder Innovations$47.32M8.31-$40.36M-$1.92N/A

Shoulder Innovations has a consensus price target of $25.50, suggesting a potential upside of 35.03%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts clearly believe Shoulder Innovations is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Shoulder Innovations
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Kewaunee Scientific beats Shoulder Innovations on 9 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Orthofix Medical?

Orthofix Medical (NASDAQ:OFIX) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Kewaunee Scientific has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.45-$92.19M-$1.54N/A
Kewaunee Scientific$282M0.35$9.62M$2.7612.49

Orthofix Medical has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Kewaunee Scientific has a net margin of 2.97% compared to Orthofix Medical's net margin of -7.41%. Kewaunee Scientific's return on equity of 11.61% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.41% -14.05% -7.17%
Kewaunee Scientific 2.97%11.61%4.82%

In the previous week, Orthofix Medical had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Orthofix Medical and 1 mentions for Kewaunee Scientific. Orthofix Medical's average media sentiment score of 0.56 beat Kewaunee Scientific's score of 0.00 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Orthofix Medical presently has a consensus target price of $14.75, indicating a potential upside of 60.64%. Given Orthofix Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Orthofix Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Orthofix Medical and Kewaunee Scientific tied by winning 8 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Avita Medical has a beta of 1.98, meaning that its share price is 98% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

Kewaunee Scientific has a net margin of 2.97% compared to Avita Medical's net margin of -56.96%. Kewaunee Scientific's return on equity of 11.61% beat Avita Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Avita Medical-56.96% N/A -78.53%
Kewaunee Scientific 2.97%11.61%4.82%

In the previous week, Avita Medical and Avita Medical both had 1 articles in the media. Avita Medical's average media sentiment score of 1.25 beat Kewaunee Scientific's score of 0.00 indicating that Avita Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avita Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kewaunee Scientific has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avita Medical$71.61M5.45-$48.59M-$1.44N/A
Kewaunee Scientific$282M0.35$9.62M$2.7612.49

Avita Medical presently has a consensus target price of $11.40, indicating a potential downside of 10.03%. Given Avita Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Avita Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avita Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Kewaunee Scientific beats Avita Medical on 9 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Mobia Medical?

Kewaunee Scientific (NASDAQ:KEQU) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

In the previous week, Kewaunee Scientific and Kewaunee Scientific both had 1 articles in the media. Kewaunee Scientific's average media sentiment score of 0.00 equaled Mobia Medical'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mobia Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kewaunee Scientific has a net margin of 2.97% compared to Mobia Medical's net margin of 0.00%. Kewaunee Scientific's return on equity of 11.61% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific2.97% 11.61% 4.82%
Mobia Medical N/A N/A N/A

Mobia Medical has a consensus target price of $20.75, suggesting a potential upside of 127.77%. Given Mobia Medical's stronger consensus rating and higher probable upside, analysts plainly believe Mobia Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

32.7% of Kewaunee Scientific shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Kewaunee Scientific has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.35$9.62M$2.7612.49
Mobia Medical$32.04M9.47-$46.50M-$20.18N/A

Summary

Kewaunee Scientific beats Mobia Medical on 9 of the 13 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KEQU vs. The Competition

MetricKewaunee ScientificHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$98.18M$5.36B$7.09B$13.24B
Dividend YieldN/A1.80%2.53%15.89%
P/E Ratio12.3824.66274.6126.05
Price / Sales0.3541.72600.5190.03
Price / Cash5.6932.6877.3851.25
Price / Book1.285.6810.926.31
Net Income$9.62M$152.11M$3.50B$361.43M
7 Day Performance0.41%-2.01%-2.11%-1.67%
1 Month Performance-5.92%-5.42%-6.34%-3.94%
1 Year Performance-21.13%2.75%8.81%2.77%

Kewaunee Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KEQU
Kewaunee Scientific
0.4099 of 5 stars
$34.16
+0.7%
N/A-23.3%$98.18M$282M12.381,231
OBIO
Orchestra BioMed
3.1502 of 5 stars
$6.22
-0.5%
$13.17
+111.7%
+149.0%$375.66M$33.48MN/A4
SI
Shoulder Innovations
2.6121 of 5 stars
$17.73
+1.2%
$25.50
+43.8%
+55.3%$364.75M$47.32MN/A75
OFIX
Orthofix Medical
2.5837 of 5 stars
$8.98
+0.3%
$14.75
+64.3%
-35.8%$364.56M$822.31MN/A1,605
RCEL
Avita Medical
1.082 of 5 stars
$11.49
+6.0%
$11.40
-0.8%
+128.8%$333.62M$71.61MN/A226

Related Companies and Tools


This page (NASDAQ:KEQU) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners